Postdoc @UCLA | PhD @scrippsresearch | https://xitter.cf/t.co/K5wjiCFNGw | 🐘@gk@mstdn.science

La Jolla
Joined April 2010
Got milk virus genomes?  (or any H5N1?)  Throw them at usher.bio and see where they land in per-segment trees of tens of thousands of public Influenza A H5N1 sequences!
3
23
2
49
9,404
For a report on our analyses of #H5N1 in cattle, see worobey bsky social
1
6
4
27
17,461
In a @VanityFair story, @KatherineEban oddly misrepresented an investigation into @GISAID and Peter Bogner by @sciencecohen and me; suggested our story was a volley in the lab leak debate; and let Bogner dismiss it as a "hit piece." Here's our response. science.org/do/10.1126/scien…
8
14
1
37
18,111
Great to see these API connections!
Had a good week participating in the NCBI Beyond Phylogenies codeathon. One of the things our team achieved was to add links between tools used for viral phylogenetics You can now: - load @nextstrain trees in Taxonium - export out NS subtrees - get clade stats with @GenSpectrum
1
5
🧵for our latest preprint on the intrahost evolution of SARS-CoV-2 virus in an immunocompromised individual (60s) with a history of cancer chronically infected for at least 471 days (ongoing) with consistently replicating viruses at a high viral load. 1/n medrxiv.org/content/10.1101/…
25
381
83
985
We've been working hard to enable quicker and easier ⚡️ access to simple but key SC2 variant statistics 📉📈 on @DiseaseOutbreak Our R package now lets any user with @GISAID credentials to quickly access these stats for surveillance efforts 🔍 & complex downstream analyses 🤓
3
12
1
37
We've also described the technical details on outbreak.info in these preprints, Genomic reports medrxiv.org/content/10.1101/… Research Library biorxiv.org/content/10.1101/…
1
4
This was a big team effort only made possible by global 🗺️ sequencing efforts and the team at @GISAID! In particular, I wanted to highlight @malkuzweny's work in building the R package. She has gone on to doing more exciting work as a PhD student in @TAlexPerkins's group!
1
4
8
we're deep into Omicron's reign. does that mean we definitely need an Omicron-specific vaccine? it's complicated for at least three big reasons: timing, Omicron's weirdness, and the vagaries of virus evolution. 1/ theatlantic.com/health/archi…
16
56
12
176
Let's try this again twitter, -h --help --info 🤓
This Post is from an account that no longer exists. Learn more
2
1
1
20
We have just released two preprints on the origin of SARS-CoV-2: 1. "The Huanan market was the epicenter of SARS-CoV-2 emergence" zenodo.org/record/6299116#.Y…
277
1,122
368
3,090
I wrote about what's next for the pandemic—the decisions we will *have* to make, if we are to bring COVID under control. 1/ theatlantic.com/science/arch…
18
86
14
244
(1/13) By the end of the Omicron wave, nearly all of us will have glimpsed spike in some form or another—injection, infection, both. I wrote about what that means... and why “widespread exposure” does not necessarily equate to “widespread protection.” theatlantic.com/health/archi…
36
203
34
546
Data on outbreak.info @DiseaseOutbreak has been updated to include BA.1.1. As noted by many, the dynamics of the sub lineages within Omicron are changing. Globally 🌍, - BA.1.1 (BA.1 + S:346K), grew and seems to have plateaued. - BA.2 📈 - BA.1 📉
1
36
4
86
In the meantime, the @DiseaseOutbreak team is working hard to keep everything up to date!
1
1
12
And as always, thanks to sequence submitters worldwide🌍 for sharing their data on @GISAID !
1
16